Heghine Khachatryan: When to Consider Ehlers–Danlos Syndromes in Patients with Bleeding Symptoms?
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared European Association for Haemophilia and Allied Disorders (EAHAD)’s post on LinkedIn, adding:
”When Should We Consider Ehlers–Danlos Syndromes in Patients with Bleeding Symptoms?
Connective tissue disorders, particularly Ehlers–Danlos Syndromes (EDS), remain under-recognized in daily hematology practice — yet they frequently present with hemorrhagic manifestations that may mimic primary hemostatic disorders.
The newly released EAHAD e-learning module (Module 21) provides valuable clinical insight into:
- Recognizing red flags in patients with unexplained bleeding
- Understanding the overlap between connective tissue fragility and hemostatic abnormalities
- Improving multidisciplinary diagnostic pathways
- Avoiding misdiagnosis of inherited bleeding disorders
As clinicians working in benign hematology and hemostasis, it is essential that we broaden our differential diagnosis when laboratory results do not fully explain the clinical phenotype.
Timely identification of EDS can significantly impact patient management, perioperative planning, and long-term follow-up.
I strongly encourage colleagues involved in bleeding disorders, women’s health, and rare disease diagnostics to explore this educational resource.”
Quoting European Association for Haemophilia and Allied Disorders (EAHAD)’s post:
”Don’t miss our e-learning module on the Ehlers-Danlos Syndromes (EDS), rare, inherited multisystemic connective tissue disorders frequently associated with bleeding symptoms and haematological challenges.”
Proceed to the video attached to the post.
Find more posts featuring Heghine Khachatryan on Hemostasis Today.
-
Feb 14, 2026, 17:18Sonal Sonu: A Compatible Crossmatch Does Not Guarantee Transfusion Safety
-
Feb 14, 2026, 17:15Nasrin Haghani: Vitamin D and Omega-3 Fatty Acids May Support Mood Regulation
-
Feb 14, 2026, 17:14Joseph Raffaele: How Gut Aging Drives Cardiovascular Risk
-
Feb 14, 2026, 17:03Mohamed Sayed Abdelmoneim: Addressing a Persistent Challenge in Posterior Circulation Ischemic Stroke
-
Feb 14, 2026, 16:58Paul Bolaji: Strengthening Stroke Care in Africa Through Collaboration and Evidence
-
Feb 14, 2026, 16:56Can we Boost Emicizumab Without Increasing Thrombosis Risk? – RPTH Journal
-
Feb 14, 2026, 16:52Akshat Jain: Transforming Care for Chronic Blood Disorders
-
Feb 14, 2026, 16:50Ahsan Syed: Why a 20-Minute Walk Boosts Brain Function Better Than Caffeine
-
Feb 14, 2026, 16:47Mofiyinfoluwa Oloba: What Actually Happens to the Brain During a Stroke